{"id":11432,"date":"2018-09-08T05:00:22","date_gmt":"2018-09-08T09:00:22","guid":{"rendered":"https:\/\/medicarereport.org\/?p=11432"},"modified":"2018-09-06T16:24:07","modified_gmt":"2018-09-06T20:24:07","slug":"with-big-name-backing-a-startup-launches-to-match-cancer-patients-with-clinical-trials","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=11432","title":{"rendered":"With big-name backing, a startup launches to match cancer patients with clinical trials"},"content":{"rendered":"<p>(By Rebecca Robbins for ST<em>A<\/em>T)<\/p>\n<p class=\"big-cap-wrap danger-zone\"><span class=\"big-cap\">SAN FRANCISCO \u2014 An ambitious startup aimed at connecting cancer patients with clinical trials launched on Thursday, one that is betting a smartphone app can help close the notorious gap between patients seeking experimental treatments and cancer centers ready to offer it. <a href=\"https:\/\/www.statnews.com\/2018\/09\/06\/with-big-name-backing-a-startup-launches-to-match-cancer-patients-with-clinical-trials\/?utm_source=STAT+Newsletters&amp;utm_campaign=a75f49bb7e-Pharmalot&amp;utm_medium=email&amp;utm_term=0_8cab1d7961-a75f49bb7e-149624405\">Continue reading article here&#8230;<\/a><\/span><\/p>\n<p class=\"big-cap-wrap danger-zone\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rebecca Robbins for STAT) SAN FRANCISCO \u2014 An ambitious startup aimed at connecting cancer patients with clinical trials launched<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-11432","post","type-post","status-publish","format-standard","hentry","category-medical-technology"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11432"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11432\/revisions"}],"predecessor-version":[{"id":11433,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/11432\/revisions\/11433"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}